BioSpin Buy Boosts Bruker BioSciences' Shares Nearly 20 Percent

Dec 03, 2007

NEW YORK (GenomeWeb News) - Bruker BioSciences’ shares bolted up 19.5 percent today following this morning’s announcement that it is buying its affiliate Bruker BioSpin for $914 million in cash and stock.

In afternoon trading, Bruker’s shares had risen $1.87 to $11.16.

Bruker BioSpin makes magnetic resonance core technology. It posted $447 million in revenue and $56.6 million in net income in 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Marine Mammal Gene Loss

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

Cell Count

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

Varied Opinions

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

This Week in PNAS

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Main menu